Skip to main content
Download PDF
Download ePub
  • Study protocol
  • Open access
  • Published:

Community health worker training to reduce mental health and substance use stigma towards patients who have disengaged from HIV/TB care in South Africa: protocol for a stepped wedge hybrid type II pilot implementation trial

Implementation Science Communications volume 5, Article number: 1 (2024) Cite this article

Abstract

Background

South Africa has deployed community health workers (CHWs) to support individuals to enter and stay in HIV/TB care. Although CHWs routinely encounter patients with mental health (particularly depression) and substance use (SU) conditions that impact their engagement in HIV/TB care, CHWs are rarely trained in how to work with these patients. This contributes to mental health and SU stigma among CHWs, a known barrier to patient engagement in care. Mental health and SU training interventions could reduce CHW stigma and potentially improve patient engagement in care, but evidence of the feasibility, acceptability, and preliminary effectiveness of these interventions is scarce. Therefore, we designed a hybrid type 2 effectiveness-implementation pilot trial to evaluate the implementation and preliminary effectiveness of a CHW training intervention for reducing depression and SU stigma in the Western Cape, South Africa.

Methods

This stepped wedge pilot trial will engage CHWs from six primary care clinics offering HIV/TB care. Clinics will be block randomized into three-step cohorts that receive the intervention at varying time points. The Siyakhana intervention involves 3 days of training in depression and SU focused on psychoeducation, evidence-based skills for working with patients, and self-care strategies for promoting CHW wellness. The implementation strategy involves social contact with people with lived experience of depression/SU during training (via patient videos and a peer trainer) and clinical supervision to support CHWs to practice new skills. Both implementation outcomes (acceptability, feasibility, fidelity) and preliminary effectiveness of the intervention on CHW stigma will be assessed using mixed methods at 3- and 6-month follow-up assessments.

Discussion

This trial will advance knowledge of the feasibility, acceptability, and preliminary effectiveness of a CHW training for reducing depression and SU stigma towards patients with HIV and/or TB. Study findings will inform a larger implementation trial to evaluate the longer-term implementation and effectiveness of this intervention for reducing CHW stigma towards patients with depression and SU and improving patient engagement in HIV/TB care.

Trial registration

ClinicalTrials.gov NCT05282173. Registered on 7 March 2022.

Introduction

Despite South Africa’s efforts to expand HIV and TB treatment, the country continues to struggle with a high incidence of HIV and TB [1]. Challenges with engaging and retaining patients in care contribute to HIV and TB incidence in this setting [1,2,3,4]. Evidence suggests that only half of all patients complete TB treatment and less than two-thirds achieve virological suppression on antiretroviral therapy (ART) for HIV [5, 6]. Without implementing strategies to enhance patient engagement in care, South Africa is unlikely to meet global targets for ending HIV and TB by 2030.

In response to this challenge, the South African Department of Health has implemented community health worker (CHW) programs to support TB and HIV care [7, 8]. CHWs conduct home visits to promote care re-engagement for individuals who have fallen out of HIV and/or TB care [8, 9]. During these visits, CHWs often encounter patients with symptoms of SU and depression due to the high prevalence of depression and substance use (SU) in these patient groups [10,11,12] and the contribution of these symptoms to HIV/TB care engagement difficulties [11,12,13]. Based on our previous work [14, 15], approximately one-third of patients with HIV/TB may screen positive for SU use or depression symptoms, with higher rates among patients with HIV/TB care disengagement.

Yet, CHWs receive limited training on how to identify and communicate with patients who have symptoms of SU or depression [16, 17]. While some mental health and SU trainings have been piloted for CHWs [16, 18, 19], this training is not consistently provided as part of the Department of Health’s CHW accreditation program. Given the well-documented association between poor mental health literacy and stigma [20, 21], this lack of training likely contributes to CHW stigma towards patients with HIV/TB and depression or SU. Indeed, our earlier work documented high levels of depression and SU stigma among South African CHWs [22,23,24]. This is cause for concern as mental health and SU stigma among health providers is known to impact healthcare quality, including the implementation of evidence-based practices and patient-centered care [25,26,27]. In addition, CHW stigma towards people with symptoms of depression or SU is a known barrier to patient re-engagement in HIV/TB care [22, 28, 29]. Consequently, interventions to reduce CHW stigma towards patients with SU or depression symptoms are needed to improve patient engagement in HIV/TB care.

Study objectives

In response to these knowledge gaps, this study aims to evaluate the initial implementation and preliminary effectiveness of a CHW training intervention for reducing SU and depression stigma towards patients who have fallen out of HIV/TB care in the Western Cape, South Africa.

The primary objective of this study is to evaluate the feasibility, acceptability, and fidelity of implementing this training. A secondary objective is to assess the preliminary effectiveness of this training intervention (compared to usual care) for reducing CHW stigma towards depression and SU towards patients who have fallen out of HIV/TB care. Implementation and preliminary effectiveness outcomes will be assessed at 3- and 6-month post-training timepoints.

Methods

This protocol is reported in accordance with the guidelines presented in the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) checklist [30] and the Consort Guidelines for Reporting Stepped Wedge-Cluster Randomised Controlled Trials [31]. See Supplementary files 1 and 2 for relevant checklists.

Study design and setting

This is a hybrid Type 2, stepped-wedge cluster randomized controlled pilot trial with a dual focus on the preliminary effectiveness of the training intervention when delivered in a real-world context and initial implementation outcomes, allowing for piloting of implementation strategies [32].

This study is being conducted within the City of Cape Town’s community health clinics located in the Khayelitsha health district within the Western Cape, South Africa. These clinics offer publicly funded, integrated HIV and TB treatment to patients from predominately low-income communities where there is a high prevalence of HIV, TB, SU, and mental health concerns [33, 34]. At these clinics, there is an existing infrastructure of CHWs who provide basic health services and home visits to patients with HIV/TB. The Western Cape Department of Health contracts non-governmental organizations (NGOs) to employ CHWs.

In collaboration with the City of Cape Town, we identified six clinics whose CHWs will receive the training. We selected clinics based on their location, the number of CHWs providing HIV/TB care, and NGO support for training of the CHWs that they employ. Each clinic will be randomized to the timing of when their CHWs receive the training intervention (versus treatment as usual) over a 1.5-month period. Clinics will be block randomized into three-step cohorts by the study statistician. Figure 1 presents an overview of the project over the trial period. CHWs within each clinic site who agree to participate will receive the training at their clinic’s assigned time. CHWs are allocated to a single clinic and community, minimizing the potential for contamination. Randomization will not affect any other TB/HIV-related service or mental health training offered to CHWs.

Fig. 1
figure 1

Overview of stepped wedge trial design and timeline. TAU, treatment as usual; 3MFU, 3-month follow-up; 6MFU, 6-month follow-up

Full size image

Participants and procedures

CHWs across all six clinics will be recruited at approximately the same time. We anticipate enrolling a minimum sample of 60 CHWs (10 CHWs per clinic). All CHWs at these clinics will be invited to participate in the training. CHWs will be eligible for study participation if they are at least 18 years old, employed as a CHW through one of two partner NGOs that provide HIV/TB services, and work with patients with HIV/TB who may have depression or substance use concerns. CHWs will be excluded if they are unable to complete the training in English or unable to provide informed consent for study participation or complete study assessments in English or isiXhosa (the main languages of the district). Trained study staff will meet with CHWs to explain the training and study procedures, enquire about their interest in study participation, and conduct eligibility screening. CHWs who are eligible and interested in participating will be asked to complete informed consent procedures followed by a baseline assessment, including self-report questions on demographic characteristics; the CHW role; knowledge of HIV, TB, depression, and SU; and stigma.

In stepped-wedge trials, all groups have different intervals of a baseline period in which they are not exposed to an intervention (which we refer to as “treatment as usual” or “TAU”) [35]. After the baseline assessment, all clusters will be informed of the timing of their training (their allocation). Each cluster will receive at least one dose of TAU. Based on the training time to which their cluster was randomized, CHWs will then be invited to participate in the Siyakhana training. In Step 1, clinics randomized to Training Time #1 will receive the training while the other clinics continue to receive TAU. In Step 2, clinics randomized to Training Time #2 will receive the training, while the final set of clinics continue to receive TAU. In Step 3, clinics randomized to Training Time #3 will receive the training.

Before their assigned training, CHWs will complete a pre-training assessment comprising most of the self-report questionnaires asked at baseline. At the pre-training assessment and on the final day of training, CHWs will complete a brief vignette-based role-play of an interaction between the CHW and a hypothetical patient with HIV and depression or SU, played by a staff member who is minimally involved in delivering the training. This will be conducted in the language CHWs use with most of their patients (English or isiXhosa), videotaped, and later coded for the presence of stigmatizing language. All CHW participants will be invited to complete a follow-up assessment approximately 3 months after their training (3MFU) and again approximately 6 months after their training (6MFU), consisting of the same questionnaires from the pre-training assessment, another videotaped roleplay, and questions about implementation outcomes. All assessments and roleplays will be conducted in English or isiXhosa (the main languages of the setting).

After the 6MFU, we will contact a subset of CHWs (up to n = 20) who participated in the training for a qualitative interview about their experiences of applying the training content in their interactions with patients and the perceived feasibility and acceptability of the training and their implementation of the training content. For these interviews, we will randomly select CHWs from the following subgroups: CHWs who report a significant decrease in depression/SU stigma, those who report no change in depression/SU stigma, and CHWs who report a significant increase in depression/SU stigma. We will also conduct qualitative interviews (up to n = 28) with leadership staff from participating clinics and NGOs and with policymakers and other stakeholders. These interviews will explore their perceptions of the feasibility and acceptability of the training and organizational barriers and facilitators to training sustainment. Interviews will continue until we reach theoretical saturation.

Interventions

Treatment as usual (TAU)

In the TAU period, CHWs will continue to deliver their usual services to patients with HIV/TB who have disengaged from care. These CHWs will have completed standard CHW training provided through the Western Cape Department of Health as part of their employment conditions. This intensive training spans 6 weeks with booster training provided on an annual basis. Training focuses on basic communication skills; information about HIV, TB, and sexually transmitted infections; clinical guidelines for these conditions; training in HIV testing and counseling; and TB/HIV adherence counseling. Adherence counseling focuses on identifying and addressing structural barriers to care engagement [15, 16]. Mental health and SU training is not currently offered as part of CHW certification [16, 17].

Siyakhana training

Within a week of completing the pre-training assessment, CHWs will be offered the Siyakhana training. The Siyakhana training was informed by Link and Phelan’s [36] stigma framework, combined with the Situated Information Motivation Behavioral Skills Model of Care Initiation and Maintenance framework (sIMB-CIM) [37] and adapted based on prior formative work [23, 24], prior training programs to improve CHW mental health and SU literacy and teach problem-solving skills [15, 18, 19, 23]. According to the Link and Phelan framework, mental health, and SU stigma occurs when CHWs label their patients who have SU and/or depression symptoms as different, attach negative stereotypes to them, and distinguish these patients from themselves and their other patients. We included information that challenged CHWs’ preconceptions of patients with SU or depression, including opportunities for direct and indirect contact with people with lived mental health and SU experience, videos of patients talking about their lived experience with mental health and SU challenges and training on non-judgmental communication. Further, the training will be conducted by registered psychological counselors combined with individuals with lived experience of depression/SU.

The sIMB-CIM model recognizes that engagement and retention in health services require accurate information about health conditions, motivation, and skills for overcoming barriers to care. Consequently, Siyakhana is designed to provide CHWs with accurate information on depression andSU and evidence-based communication, motivational and problem-solving skills to support non-stigmatizing interactions with patients that may help promote patient re-engagement in care. The Siyakhana training will also teach CHWs self-care strategies (see Table 1 for an overview of the training content).

Table 1 Siyakhana training components
Full size table

Training will be delivered in English like other CHW trainings offered by the Western Cape Department of Health. Our training team consists of English and isiXhosa mother-tongue speakers and will be able to address questions and further explain concepts in isiXhosa if needed.

Implementation strategy

The implementation strategy involves two components. First, as intervention components that involve social contact with individuals with lived experience have the most empirical support for stigma reduction [26, 38,39,40,41], peers with lived personal and family experience of mental health and SU will help deliver the training. Second, we will provide CHWs with clinical supervision and support to apply the training content in their work with patients. Our formative and prior work with CHW-delivered depression and SU interventions emphasized the importance of supervision to support CHWs to use new skills and to prevent burnout among these frontline workers who witness the difficult circumstances of their patients [16, 42, 43]. Each CHW cluster will receive group supervision. Like previous studies [14, 15, 44], a registered psychological counselor or social worker will provide supervision. During supervision, CHWs will re-cap the skills learned during training, discuss challenges with applying these skills, and receive clinical debriefing and psychosocial support for challenging patient interactions, and for practicing self-care strategies. This supervisor will be supported by psychologists on the research team.

Study measures

The data collection schedule is shown in Table 2. As this is a hybrid pilot trial, we will assess both implementation and effectiveness outcomes.

Table 2 Description of measures and assessment schedule
Full size table

Implementation outcomes

Guided by Proctor’s model of implementation outcomes [47], we will use mixed methods to assess the feasibility, acceptability, and fidelity of the CHW training from the perspective of the CHW, organization, and other key stakeholders. Haroz et al.’s [45] dissemination and implementation measure will quantitatively assess implementation outcomes among CHWs at 3MFU and 6MFU. For this measure, items within each of the acceptability and feasibility subscales are rated on a four-point scale (0 = “not at all”, 3 = “a lot”), summed, and averaged for a final subscale score. Feasibility will also be assessed via the percentage of training sessions attended across all CHWs (> 75% of CHW attendance will be used as a benchmark).

We will randomly select 20% of the CHW roleplays conducted at the 3MFU and 6MFU assessments to rate fidelity to the use of a nonjudgmental, non-stigmatizing way of working with patients. Raters will use a pre-determined checklist to assess roleplays for the presence of stigmatizing language and behaviors, delivery of skills learned in training, provision of correct information, and the presence of positive, supportive interactions with patients. A fidelity score will be calculated for each rated roleplay based on the proportion of key intervention components delivered as intended across all interactions. A final fidelity score, made up of the average of individual fidelity scores, will be calculated.

In addition, qualitative feedback from CHWs, organizational leadership, and other key stakeholders will be used to assess feasibility and acceptability of training as well as barriers and facilitators to implementation and fidelity at 6MFU. Interview guides will be developed using open-ended questions and structured probes based on Proctor’s definitions of acceptability, feasibility, and fidelity [47] and the Consolidated Framework for Implementation Research [48].

Preliminary effectiveness outcomes

CHW stigma

CHW stigma towards depression and SU will be assessed at each timepoint through the Social Distance Scale (SDS), a widely used measure of mental health and substance use stigma [46, 49, 50]. Participants will be presented with a vignette of a patient with HIV and symptoms of depression and another vignette of a patient with HIV and symptoms of a substance use disorder (as defined by the DSM-5). These vignettes were informed by previous work in this setting [51, 52] and our pilot test [24]. Slightly different versions of the vignettes will be presented at each timepoint. For each vignette, participants will be asked to rate their willingness to engage with the hypothetical patient across six social interactions on a 4-point scale from (1) “definitely” to (4) “definitely not”. Scores are summed to create an overall score, with higher scores indicating a desire for greater social distance from the patient, and therefore, greater stigma. To supplement the SDS, CHW roleplays at pre-training, 3MFU and 6MFU will be qualitatively coded for the presence of stigmatizing language and behaviors.

Additional measures

CHW and other stakeholder participants will be asked to complete a demographic questionnaire that includes questions about age, gender, education level, primary language, job title, and length of time in their current position and occupation.

Planned analyses

Implementation outcomes (primary analysis)

Quantitative data on feasibility, acceptability, and fidelity will be analyzed descriptively (M, SD, range). Thematic analysis [53] will be used to analyze qualitative data on implementation outcomes and barriers. Initial concepts will be identified based on the interview guide and an observation record. Concepts will be used to develop a codebook, and two trained independent coders will code each transcript. NVivo will be used to organize the data according to each code. The research team will review the coded transcripts to determine emerging themes. Final themes will be agreed upon and inter-rater reliability of coding assessed. For the component of this aim that focuses on barriers to implementation, the CFIR [48] will guide coding so that we can identify implementation barriers that require prioritization when scaling the training.

We will integrate qualitative and quantitative data using a convergent, mixed methods design [54]. We will compare qualitative and quantitative data for each implementation outcome separately with an equal emphasis on the qualitative and quantitative. We will create study diagrams for each implementation outcome with the key findings across qualitative and quantitative data in separate columns, allowing for a comparison and integration of findings. We will focus on points for integration where the qualitative and quantitative findings are consistent with each other, contradictory, and/or can provide additional meaning.

Preliminary effectiveness outcomes (secondary analysis)

The primary goal of this study is to establish the feasibility and acceptability of the training, and therefore all effectiveness analyses are considered preliminary. We will conduct descriptive analyses (e.g., mean, standard deviation) to summarize CHW stigma, using the continuous SDS score. To account for the stepped wedge study design, we will fit a linear mixed model for depression and a separate model for SU stigma. This analytic approach will allow us to account for both random effects of the clinic and CHW and fixed effects of time and intervention. All models will follow intent-to-treat principles: participants will be analyzed based on their initial randomization assignments and all data will be included, regardless of subsequent dropout or missing data. We will analyze the within- and between-group effects. The within-group effect will evaluate changes in stigma before and after receiving the training with CHWs from the same clinic, and the between-group effect will compare the CHW training to TAU. An F-test will examine the between- and within-clinic intervention effects. Covariates (i.e., CHW demographic and job-related characteristics) will be included in the models. The models will account for any baseline differences in stigma between clinics and individual CHWs.

For these analyses (assuming an intra-class correlation of 0.1 within clinic and 0.3 within person), a minimum of 60 CHWs will need to be enrolled to achieve 86% power at a significance level of 0.05 and a CHW training effect of 0.63, and 96% power to detect a training effect of 0.75. Anticipated standardized effect sizes were defined from a meta-analysis of 13 randomized clinical trials of mental health stigma reduction interventions that show a standardized effect size of 0.63 on measures of stigma [38] and prior work in sub-Saharan Africa using the SDS to test changes in mental health stigma among community mental health volunteers that had an effect size of 0.75 [49].

Ethics and dissemination

Ethics approval has been granted by the SAMRC’s Human Research Ethics Committee (EC039-10/2021) and the City of Cape Town. The trial is registered on clinicialtrials.gov (NCT05282173). Informed consent will be obtained from all potential CHW and stakeholder participants prior to enrolment. During the consent process, participants will be informed of all foreseeable risks of study involvement, that participation is voluntary, and that they may withdraw their consent without any consequences to their role or employment.

To ensure confidentiality, a unique participant identification number will be used to identify and link the various study forms. We will enter quantitative data into a password-protected REDCap electronic database. These data will be de-identified to protect participants’ identities. All data not stored electronically will be stored in double-locked filing cabinets in designated locked offices. Forms with personal identifying information will be stored separately from case report forms. Video and audio-recordings, identified only by the participant identification number, will be uploaded into a secure database that only study staff can access. Once uploaded, these recordings will be deleted from the recording device.

The main risk associated with this study is the risk of psychological distress or discomfort. To minimize this risk, we will train all research staff to recognize and respond appropriately to signs of discomfort and distress. This will include debriefing with participants and referring them to local mental health and SU services. Our study team includes registered psychological counselors and psychologists who have the correct competencies to debrief distressed participants and ensure they access appropriate care.

Study findings will be disseminated through presentations at local, national and international conferences and peer-reviewed journals. We will also present the study findings to the City of Cape Town and NGOs participating in this implementation pilot trial.

Data and trial management

A data monitoring committee was not established as this trial involves training health providers in how to work in non-stigmatizing, person-centered ways with patients. Any serious adverse events will be reported to the ethics committee and study sponsor.

Role of trial sponsor and funder

This pilot implementation trial was funded by the National Institute of Mental Health (NIMH) grant R34MH122268, awarded to Drs. Magidson and Myers. The South African Medical Research Council is as the trial sponsor. The sponsors and funders play no role in study design, data collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the report for publication.,

Discussion

Although CHW stigma towards patients with mental health and SU concerns is a major barrier to TB/HIV engagement in low and middle-income countries like South Africa [22, 28], relatively few CHW-level mental health and SU stigma reduction interventions have been tested and implemented in these settings [39,40,41, 55, 56]. Limited evidence of the feasibility, acceptability, and effectiveness of these interventions for shifting CHW-level stigma has likely affected health service planners' willingness to invest in these interventions.

This hybrid pilot trial will respond to these knowledge gaps by evaluating both the implementation and preliminary effectiveness of a stigma reduction training for reducing CHW stigma towards depression and SU to ultimately improve patient re-engagement in TB/HIV care. Study findings will advance scientific knowledge by providing some of the first evidence for the feasibility, acceptability, and barriers to implementing provider-level stigma reduction interventions within real-world health services. It will also provide some of the first initial evidence of whether this intervention holds promise for shifting CHW stigma towards patients with depression or SU who have disengaged from HIV/TB care.

This trial has several strengths. First, the Siyakhana training is innovative as it includes both education and contact-based components. Previous studies from LMICs have not evaluated the effects of combining these evidence-based intervention components on provider stigma towards people with mental health and/or SU concerns [56]. Second, in contrast to other provider-level stigma reduction interventions that target only one stigmatized condition, this intervention targets both depression and SU stigma. If we find promising intervention effects for both types of stigmas, this will suggest that the Siyakhana training could offer a wider range of benefits than a training focused on mental health or SU stigma alone. This could increase the chances of future implementation in resource-constrained health services. Third, this study will assess whether changes in stigma are evident at 6MFU, adding to the very limited evidence of the sustained effects of these interventions [41, 56]. Fourth, this study’s testing of the feasibility and acceptability of an intervention and its implementation strategy addresses a critical gap in the mental health and SU stigma reduction literature from LMICs [55]. Fifth, this study will leverage a low-cost, existing infrastructure of CHWs, currently deployed throughout South Africa to trace patients with TB/HIV who have disengaged from care in their homes; maximizing opportunities for wider adoption and scale up of this intervention should the findings from future implementation of the training in a fully powered implementation trial suggest benefits for patient engagement in care.

We have anticipated potential challenges to study implementation. First, CHW turnover is high in this setting and may impact on CHW retention in the study at 6MFU. To limit participant attrition, we will employ similar retention strategies to those we have used in other CHW trials where we have obtained 6MFU rates greater than 80% [15]. Second, there may be other initiatives to support CHWs to deliver mental health and SU interventions to people with HIV/TB that may affect trial findings. To account for this, we will monitor and document any additional training that CHWs are exposed to during the study.

In summary, this study will yield important information on the feasibility and acceptability of the Siyakhana intervention and its implementation strategy as well as preliminary information on the effectiveness of this training for reducing CHW stigma towards depression and SU. Should this pilot study yield promising implementation and effectiveness outcomes, findings will be used to inform a larger trial to evaluate the longer-term implementation and effectiveness of this intervention for reducing CHW stigma towards patients with depression and SU concerns and improving patient engagement in HIV/TB care.

Trial status

CHW and stakeholder recruitment commenced on 8 June 2022 and is expected to conclude in January 2024.

Availability of data and materials

De-identified data and study materials are available upon written request.

References

  1. Osman M, et al. Key changes in the public health response to TB and HIV in South Africa. Int J Tuberc Lung Dis. 2020;24(8):857–9.

    Article  CAS  PubMed  Google Scholar 

  2. Hannaford A, et al. Mobility and structural barriers in rural South Africa contribute to loss to follow up from HIV care. AIDS Care. 2021;33(11):1436–44.

    Article  PubMed  Google Scholar 

  3. Moodley N, et al. “They are inconveniencing us” - exploring how gaps in patient education and patient centred approaches interfere with TB treatment adherence: perspectives from patients and clinicians in the Free State Province, South Africa. BMC Public Health. 2020;20(1):454.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Shapiro AE, et al. Completion of the tuberculosis care cascade in a community-based HIV linkage-to-care study in South Africa and Uganda. J Int AIDS Soc. 2018;21(1):e25065.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Naidoo P, et al. The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges. J Infect Dis. 2017;216(suppl_7):S702-s713.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Zuma K, et al. The HIV Epidemic in South Africa: Key Findings from 2017 National Population-Based Survey. Int J Environ Res Public Health. 2022;19(13):8125.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Mash R, et al. A framework for implementation of community-orientated primary care in the Metro Health Services, Cape Town, South Africa. Afr J Prim Health Care Fam Med. 2020;12(1):e1–5.

    Article  PubMed  Google Scholar 

  8. Thomas LS, Buch E, Pillay Y. An analysis of the services provided by community health workers within an urban district in South Africa: a key contribution towards universal access to care. Hum Resour Health. 2021;19(1):22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ngcobo S, et al. Roles, barriers, and recommendations for community health workers providing community-based HIV Care in Sub-Saharan Africa: a review. AIDS Patient Care STDS. 2022;36(4):130–44.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Myers B, et al. Smoked drug use in patients with TB is associated with higher bacterial burden. Int J Tuberc Lung Dis. 2023;27(6):444–50.

    Article  CAS  PubMed  Google Scholar 

  11. Myers B, et al. Associations between patterns of alcohol use and viral load suppression amongst women living with HIV in South Africa. AIDS Behav. 2021;25(11):3758–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Peltzer K, et al. Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South Africa. BMC Psychiatry. 2012;12:89.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Truong M, et al. Depression and anxiety as barriers to art initiation, retention in care, and treatment outcomes in KwaZulu-Natal. South Africa EClinicalMedicine. 2021;31:100621.

    Article  PubMed  Google Scholar 

  14. Magidson JF, et al. Project Khanya: results from a pilot randomized type 1 hybrid effectiveness-implementation trial of a peer-delivered behavioural intervention for ART adherence and substance use in HIV care in South Africa. J Int AIDS Soc. 2021;24 Suppl 2(Suppl 2):e25720.

    Article  PubMed  Google Scholar 

  15. Myers B, et al. Comparing dedicated and designated approaches to integrating task-shared psychological interventions into chronic disease care in South Africa: a three-arm, cluster randomised, multicentre, open-label trial. Lancet. 2022;400(10360):1321–33.

    Article  PubMed  Google Scholar 

  16. Jacobs Y, et al. Task Sharing or Task Dumping: Counsellors Experiences of Delivering a Psychosocial Intervention for Mental Health Problems in South Africa. Community Ment Health J. 2021;57(6):1082–93.

    Article  CAS  PubMed  Google Scholar 

  17. Sorsdahl K, et al. Integration of mental health counselling into chronic disease services at the primary health care level: Formative research on dedicated versus designated strategies in the Western Cape, South Africa. J Health Serv Res Policy. 2021;26(3):172–9.

    Article  PubMed  Google Scholar 

  18. Scott K, et al. Training the addiction treatment workforce in HIV endemic regions: an overview of the South Africa HIV Addiction Technology Transfer Center initiative. Train Educ Prof Psychol. 2020;14(1):78–85.

    PubMed  PubMed Central  Google Scholar 

  19. Sibeko G, et al. Piloting a mental health training programme for community health workers in South Africa: an exploration of changes in knowledge, confidence and attitudes. BMC Psychiatry. 2018;18(1):191.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Green B, et al. Stigma and behavioral health literacy among individuals with proximity to mental health or substance use conditions. J Ment Health. 2021;30(4):481–7.

    Article  PubMed  Google Scholar 

  21. Simões de Almeida R, et al. Mental health literacy and stigma in a municipality in the North of Portugal: a cross-sectional study. Int J Environ Res Public Health. 2023;20(4):3318.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Regenauer KS, et al. “That person stopped being human”: Intersecting HIV and substance use stigma among patients and providers in South Africa. Drug Alcohol Depend. 2020;216:108322.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Magidson JF, et al. “It’s all about asking from those who have walked the path”: patient and stakeholder perspectives on how peers may shift substance use stigma in HIV care in South Africa. Addict Sci Clin Pract. 2022;17(1):52.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Regenauer KS, Rose AL, Belus JM, Johnson K, Ciya N, Ndamase S, Jacobs Y, Staniland L, Sibeko G, Bassett IV, Joska JA, Myers B*, Magidson JF*. Piloting Siyakhana: A community health worker training to reduce substance use and depression stigma in South African HIV and TB care. PLOS Global Public Health. In press.

  25. Al Saif F, et al. Association between attitudes of stigma toward mental illness and attitudes toward adoption of evidence-based practice within health care providers in Bahrain. PLoS ONE. 2019;14(12):e0225738.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Bielenberg J, et al. A systematic review of stigma interventions for providers who treat patients with substance use disorders. J Subst Abuse Treat. 2021;131:108486.

    Article  CAS  PubMed  Google Scholar 

  27. Henderson C, et al. Mental health-related stigma in health care and mental health-care settings. Lancet Psychiatry. 2014;1(6):467–82.

    Article  PubMed  Google Scholar 

  28. Magidson JF, et al. “Someone who is in this thing that I am suffering from”: the role of peers and other facilitators for task sharing substance use treatment in South African HIV care. Int J Drug Policy. 2019;70:61–9.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Myers B, et al. Patient preferences for the integration of mental health counseling and chronic disease care in South Africa. Patient Prefer Adherence. 2018;12:1797–803.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Chan AW, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Hemming K, et al. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 2018;363:k1614.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Landes SJ, McBain SA, Curran GM. An introduction to effectiveness-implementation hybrid designs. Psychiatry Res. 2019;280:112513.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Lee JS, et al. Intersecting relationships of psychosocial and structural syndemic problems among people with HIV in South Africa: using network analysis to identify influential problems. AIDS Behav. 2023;27(6):1741–56.

    Article  PubMed  Google Scholar 

  34. Wechsberg WM, et al. Contextualizing gender differences and methamphetamine use with HIV prevalence within a South African community. Int J Drug Policy. 2014;25(3):583–90.

    Article  PubMed  Google Scholar 

  35. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182–91.

    Article  PubMed  Google Scholar 

  36. Link BG, Phelan JC. Conceptualizing Stigma. Ann Rev Sociol. 2001;27(1):363–85.

    Article  Google Scholar 

  37. Rivet Amico K. A situated-Information Motivation Behavioral Skills Model of Care Initiation and Maintenance (sIMB-CIM): an IMB model based approach to understanding and intervening in engagement in care for chronic medical conditions. J Health Psychol. 2011;16(7):1071–81.

    Article  CAS  PubMed  Google Scholar 

  38. Thornicroft G, et al. Evidence for effective interventions to reduce mental-health-related stigma and discrimination. Lancet. 2016;387(10023):1123–32.

    Article  PubMed  Google Scholar 

  39. Javed A, et al. Reducing the stigma of mental health disorders with a focus on low- and middle-income countries. Asian J Psychiatr. 2021;58:102601.

    Article  PubMed  Google Scholar 

  40. Livingston JD, et al. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39–50.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Makhmud A, Thornicroft G, Gronholm PC. Indirect social contact interventions to reduce mental health-related stigma in low- and middle-income countries: systematic review. Epidemiol Psychiatr Sci. 2022;31:e79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Brooke-Sumner C, et al. Strategies for supporting the implementation of a task-shared psychological intervention in South Africa’s chronic disease services: qualitative insights from health managers’ experiences of project MIND. Glob Health Action. 2022;15(1):2123005.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Myers B, et al. Community health worker-delivered counselling for common mental disorders among chronic disease patients in South Africa: a feasibility study. BMJ Open. 2019;9(1):e024277.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Parry CDH, et al. Motivational interviewing and problem-solving therapy intervention for patients on antiretroviral therapy for HIV in Tshwane, South Africa: a randomized controlled trial to assess the impact on alcohol consumption. Addiction. 2023;118:2164–76.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Haroz EE, et al. Measuring implementation in global mental health: validation of a pragmatic implementation science measure in eastern Ukraine using an experimental vignette design. BMC Health Serv Res. 2019;19(1):262.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Swed S, et al. Stigmatizing attitudes towards depression among university students in Syria. PLoS ONE. 2022;17(9):e0273483.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Proctor E, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.

    Article  PubMed  Google Scholar 

  48. Damschroder LJ, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):50.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Abayomi O, Adelufosi A, Olajide A. Changing attitude to mental illness among community mental health volunteers in south-western Nigeria. Int J Soc Psychiatry. 2013;59(6):609–12.

    Article  CAS  PubMed  Google Scholar 

  50. Adewuya AO, Makanjuola RO. Social distance towards people with mental illness amongst Nigerian university students. Soc Psychiatry Psychiatr Epidemiol. 2005;40(11):865–8.

    Article  PubMed  Google Scholar 

  51. Sorsdahl K, Stein DJ, Myers B. Negative attributions towards people with substance use disorders in South Africa: variation across substances and by gender. BMC Psychiatry. 2012;12:101.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Sorsdahl KR, Stein DJ. Knowledge of and stigma associated with mental disorders in a South african community sample. J Nerv Ment Dis. 2010;198(10):742–7.

    Article  PubMed  Google Scholar 

  53. Braun V, Clarke V. What can “thematic analysis” offer health and wellbeing researchers? Int J Qual Stud Health Well-being. 2014;9:26152.

    Article  PubMed  Google Scholar 

  54. Palinkas LA, Mendon SJ, Hamilton AB. Innovations in Mixed Methods Evaluations. Annu Rev Public Health. 2019;40:423–42.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Kemp CG, et al. Implementation science and stigma reduction interventions in low- and middle-income countries: a systematic review. BMC Med. 2019;17(1):6.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Clay J, et al. Core components of mental health stigma reduction interventions in low- and middle-income countries: a systematic review. Epidemiol Psychiatr Sci. 2020;29:e164.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank our NGO partners for their enthusiastic support for the project and for allowing us to train the CHWs they employ.

Funding

This research was funded by the National Institute of Mental Health (NIMH) grant R34MH122268, awarded to Drs. Magidson and Myers. KR’s time was supported by the National Institute on Drug Abuse (NIDA) grant R36DA057167, and AR’s time was supported by NIMH grant F31MH123020.

Author information

Authors and Affiliations

  1. Curtin enAble Institute, Faculty of Health Sciences, Curtin University, Kent Street, Perth, WA, Australia

    Bronwyn Myers

  2. Mental Health, Alcohol, Substance Use and Tobacco Research Unit, South African Medical Research Council, Parow, Cape Town, South Africa

    Bronwyn Myers, Kim Johnson, Sibabalwe Ndamase & Nonceba Ciya

  3. Department of Psychiatry and Mental Health, Division of Addiction Psychiatry, University of Cape Town, Cape Town, South Africa

    Bronwyn Myers & Goodman Sibeko

  4. Department of Psychology, University of Maryland, College Park, College Park, MD, USA

    Kristen S. Regenauer, Alexandra Rose, Imani Brown & Jessica F. Magidson

  5. Department of Psychiatry and Mental Health, Division of Neuropsychiatry, University of Cape Town, HIV Mental Health Research Unit, Cape Town, South Africa

    John Joska

  6. Division of Infectious Diseases, Medical Practice Evaluation Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA

    Ingrid V. Bassett

  7. Department of Clinical Research, Division of Clinical Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland

    Jennifer M. Belus

  8. Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland

    Jennifer M. Belus

  9. Department of Epidemiology and Biostatistics, University of Maryland, College Park, MD, USA

    Tianzhou (Charles) Ma

Authors
  1. Bronwyn Myers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristen S. Regenauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexandra Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kim Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sibabalwe Ndamase
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nonceba Ciya
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Imani Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. John Joska
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ingrid V. Bassett
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jennifer M. Belus
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tianzhou (Charles) Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Goodman Sibeko
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jessica F. Magidson
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JFM and BM conceptualized, designed, and secured funding for the project, with input from JJ, TM, JMB, IB, and GS. JFM and BM are the primary investigators and supervisors of the project. KSR created the training manual based on previous trainings by BM and GS, with help from KJ, AR, and under the supervision of JFM and BM. KJ and KSR are project administrators, with help from NC, SN, and ALR. NC and SN are involved in training implementation and data collection with the support of ALR, KJ, KSR, and IB. TM helped design the statistical analysis plan for the study with inputs from JMB. BM wrote the first draft of the manuscript with help from all co-authors. All authors contributed substantially to the development of this protocol. All authors read and approved the final version.

Corresponding author

Correspondence to Bronwyn Myers.

Ethics declarations

Ethics approval and consent to participate

Ethics approval has been granted by the SAMRC’s Human Research Ethics Committee (EC039-10/2021) and the City of Cape Town. The trial is registered on clinicialtrials.gov (NCT05282173). Informed consent will be obtained from all potential CHW and stakeholder participants prior to enrolment.

Consent for publication

Not applicable as this is a study protocol.

Competing interests

The authors declare they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

SPIRIT 2013: Recommended items to address in a clinical trial protocol.

Additional file 2.

Consort checklist for stepped wedge trials.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Myers, B., Regenauer, K.S., Rose, A. et al. Community health worker training to reduce mental health and substance use stigma towards patients who have disengaged from HIV/TB care in South Africa: protocol for a stepped wedge hybrid type II pilot implementation trial. Implement Sci Commun 5, 1 (2024). https://0-doi-org.brum.beds.ac.uk/10.1186/s43058-023-00537-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s43058-023-00537-w

Keywords

Implementation Science Communications

ISSN: 2662-2211